Defining Diffuse Large B-Cell Lymphoma Immunotypes by CD8+ T Cells and Natural Killer Cells.
Jing QiLu XuDongping HuangHesheng HeJunping YaoJing ZhangYouhai XuLi Yang
Published in: Journal of oncology (2022)
This study assessed immune cells as prognostic factors in DLBCL, constructed an immune subtype that could be used to identify patients who would benefit from ICB, and constructed a model to predict the immune subtype.